We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $110B
1-Year Est. Return 4.8%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
-4.89%
1 Year Est. Return
+4.8%
3 Year Est. Return
+123.53%
5 Year Est. Return
+125.55%
10 Year Est. Return
+1,754.37%
AUM
$120B
AUM Growth
-$14.7B
Cap. Flow
-$4.33B
Cap. Flow %
-3.6%
Top 10 Hldgs %
43.4%
Holding
286
New
21
Increased
69
Reduced
159
Closed
20

Top Sells

Rank Stock Value
1
DDOG icon
Datadog
DDOG
+$1.18B
2
NET icon
Cloudflare
NET
+$1.06B
3
SHOP icon
Shopify
SHOP
+$680M
4
BNTX icon
BioNTech
BNTX
+$668M
5
META icon
Meta Platforms (Facebook)
META
+$595M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.38%
2 Technology 25.51%
3 Communication Services 18.13%
4 Healthcare 9.12%
5 Financials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMND icon
101
Lemonade
LMND
$4.1B
$204M 0.17%
2,866,446
-75,610
-3% -$5.08M
DNLI icon
102
Denali Therapeutics
DNLI
$3.97B
$203M 0.17%
12,310,889
+719,304
+6% +$12.1M
BZ icon
103
Kanzhun
BZ
$7.36B
$203M 0.17%
9,955,584
+1,390,882
+16% +$30.1M
BROS icon
104
Dutch Bros
BROS
$9.26B
$198M 0.16%
3,230,676
-266,391
-8% -$15.1M
COIN icon
105
Coinbase
COIN
$40.5B
$187M 0.16%
829,081
+241,659
+41% +$72M
ECL icon
106
Ecolab
ECL
$79.9B
$181M 0.15%
691,003
-20,664
-3% -$5.5M
AAPL icon
107
Apple
AAPL
$4.57T
$180M 0.15%
663,344
-47,526
-7% -$12.8M
YETI icon
108
Yeti Holdings
YETI
$3.95B
$174M 0.14%
3,945,196
+1,330,278
+51% +$51.2M
DOCS icon
109
Doximity
DOCS
$4.88B
$164M 0.14%
3,711,340
-138,422
-4% -$7.77M
RELY icon
110
Remitly
RELY
$5.14B
$161M 0.13%
11,658,558
+3,790,210
+48% +$55.1M
UTHR icon
111
United Therapeutics
UTHR
$23.1B
$157M 0.13%
+323,016
New +$150M
ADI icon
112
Analog Devices
ADI
$190B
$154M 0.13%
568,465
-12,377
-2% -$3.11M
KNF icon
113
Knife River
KNF
$3.79B
$150M 0.12%
2,128,401
-70,370
-3% -$4.94M
IBN icon
114
ICICI Bank
IBN
$108B
$140M 0.12%
4,709,302
-175,225
-4% -$5.38M
PG icon
115
Procter & Gamble
PG
$339B
$129M 0.11%
896,945
-22,345
-2% -$3.29M
BBD icon
116
Banco Bradesco
BBD
$36.7B
$127M 0.11%
38,275,506
+10,301,395
+37% +$35.1M
BC icon
117
Brunswick
BC
$5.28B
$125M 0.1%
1,678,211
-131,691
-7% -$8.93M
CME icon
118
CME Group
CME
$94.8B
$122M 0.1%
446,036
-11,386
-2% -$3.09M
BNTX icon
119
BioNTech
BNTX
$23.5B
$119M 0.1%
1,244,867
-6,634,492
-84% -$668M
MDB icon
120
MongoDB
MDB
$32.1B
$112M 0.09%
+267,331
New +$97.3M
BABA icon
121
Alibaba
BABA
$308B
$109M 0.09%
740,365
+368,760
+99% +$60.1M
COUR icon
122
Coursera
COUR
$1.54B
$107M 0.09%
14,590,942
+7,184,167
+97% +$62.6M
MNDY icon
123
monday.com
MNDY
$3.94B
$107M 0.09%
723,655
+15,377
+2% +$2.59M
TFII icon
124
TFI International
TFII
$11.5B
$107M 0.09%
1,029,871
+10,693
+1% +$995K
BLLN
125
BillionToOne Inc
BLLN
$4.41B
$104M 0.09%
+1,268,163
New +$129M

Similar funds

Baillie Gifford & Co's Q4 2025 Portfolio in Review

As of Q4 2025, Baillie Gifford & Co held 286 positions worth $120B, down 11% from $135B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Baillie Gifford & Co withdrew a net $4.33B in Q4 2025, closing 20 positions and reducing 159 holdings. Its most notable exit was Pinterest, an estimated $251M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, down from 30% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Baillie Gifford & Co opened a new position in Medline Inc worth $437M.

  • Baillie Gifford & Co's largest Q4 2025 buy was Medline Inc: 10,410,371 shares worth $437M.
  • Baillie Gifford & Co added most to Axon Enterprise in Q4 2025, an estimated $941M increase.
  • Baillie Gifford & Co's biggest Q4 2025 reduction was Datadog, cutting an estimated $1.18B.
  • Baillie Gifford & Co fully exited Pinterest in Q4 2025, selling an estimated $251M.
  • Baillie Gifford & Co's ten largest holdings make up 43% of its $120B portfolio in Q4 2025.
  • Baillie Gifford & Co opened 21 new positions and closed 20 in Q4 2025.
  • Baillie Gifford & Co's portfolio value fell 11% quarter-over-quarter to $120B.

Based on Baillie Gifford & Co's 13F filing for Q4 2025, filed 23 Jan 2026.